Friday, 29 January 2021

UK vaccine strategy 'paying off' as latest trials boost stockpiles

Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs * Coronavirus – latest updates * See all our coronavirus coverage Britain has cemented its status as one of the world’s leading buyers of effective Covid vaccines after two more pharmaceutical companies reported positive trial results – potentially growing the UK stockpile by 90m doses. The US drugmaker Johnson & Johnson announced on Friday that its vaccine – which requires only one dose – is effective. This followed Thursday’s news that the Novavax vaccine, which will be manufactured in the UK, performed well in phase 3 trials. Continue reading...
http://dlvr.it/RrdNqf
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

The Untold Story of Polish Refugees in Uganda

A forgotten chapter of survival in exile during World War II By  Anna Adima  for NEWLINES MAGAZINE  Anna Adima is a German-Ugandan writer an...

  • The Universal Drink
    The making—and selling—of Coca-Cola. By  E. J. Kahn, Jr. , THE NEW YORKER,  Profiles February 6, 1959 Photograph by George Marks / Retrofile...
  • Manifold Destiny
    A legendary problem and the battle over who solved it. By  Sylvia Nasar  and  David Gruber , THE NEW YORKER,  Annals of m athematics   Augus...